Francesco Maria Lavino - Net Worth and Insider Trading

Francesco Maria Lavino Net Worth

The estimated net worth of Francesco Maria Lavino is at least $0 dollars as of 2024-05-03. Francesco Maria Lavino is the Chief Commercial Officer of Nabriva Therapeutics PLC and owns about 64 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in Francesco Maria Lavino's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Francesco Maria Lavino has not made any transactions after 2019-08-22 and currently still holds the listed stock(s).

Transaction Summary of Francesco Maria Lavino

Francesco Maria Lavino Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Francesco Maria Lavino owns 1 companies in total, including Nabriva Therapeutics PLC (NBRVF) .

Click here to see the complete history of Francesco Maria Lavino’s form 4 insider trades.

Insider Ownership Summary of Francesco Maria Lavino

Ticker	Comapny	Transaction Date	Type of Owner
NBRVF	Nabriva Therapeutics PLC	2019-08-22	Chief Commercial Officer

Francesco Maria Lavino Latest Holdings Summary

Francesco Maria Lavino currently owns a total of 1 stock. Francesco Maria Lavino owns 64 shares of Nabriva Therapeutics PLC (NBRVF) as of August 22, 2019, with a value of $0.

Latest Holdings of Francesco Maria Lavino

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
NBRVF	Nabriva Therapeutics PLC	2019-08-22	64	0.00	0

Holding Weightings of Francesco Maria Lavino

Francesco Maria Lavino Form 4 Trading Tracker

According to the SEC Form 4 filings, Francesco Maria Lavino has made a total of 2 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Nabriva Therapeutics PLC is the acquisition of 19 shares on August 22, 2019, which cost Francesco Maria Lavino around $9,792.

Insider Trading History of Francesco Maria Lavino

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Francesco Maria Lavino Trading Performance

GuruFocus tracks the stock performance after each of Francesco Maria Lavino's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Francesco Maria Lavino is -21.35%. GuruFocus also compares Francesco Maria Lavino's trading performance to market benchmark return within the same time period. The performance of stocks bought by Francesco Maria Lavino within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Francesco Maria Lavino's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Francesco Maria Lavino

Average Return

Average return per transaction

Outperforming Transactions

0 out of 3 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-5.39
Relative Return to S&P 500(%)	-7.05

Francesco Maria Lavino Ownership Network

Ownership Network List of Francesco Maria Lavino

No Data

Ownership Network Relation of Francesco Maria Lavino

Francesco Maria Lavino Owned Company Details

What does Nabriva Therapeutics PLC do?

Who are the key executives at Nabriva Therapeutics PLC?

Francesco Maria Lavino is the Chief Commercial Officer of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .

Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nabriva Therapeutics PLC Insider Transactions

No Available Data

Francesco Maria Lavino Mailing Address

Above is the net worth, insider trading, and ownership report for Francesco Maria Lavino. You might contact Francesco Maria Lavino via mailing address: 1000 Continental Drive, Suite 600, King Of Prussia Pa 19406.

Discussions on Francesco Maria Lavino

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.